搜尋結果
Chan, C. P. ,
Yuan-Soon, H. ,
Wang, Y. J. ,
Lan, W. H. ,
Chen, L. I. ,
Chen, Y. J. ,
Lin, B. R. ,
Chang, M. C. &
Jeng, J. H. ,
3月 1 2005 ,
於: Toxicology. 208 ,
1 ,
p. 95-104 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thromboxanes B
100%
2-cresol
96%
Thromboxanes
65%
cresol
62%
3-cresol
61%
Ho, P. Y. ,
Liang, Y. C. ,
Ho, Y. S. ,
Chen, C. T. &
Lee, W. S. ,
8月 2004 ,
於: International Journal of Cancer. 111 ,
1 ,
p. 51-59 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terbinafine
100%
Endothelial Cells
52%
Cell Proliferation
47%
Umbilicus
43%
Thymidine
18%
Ho, P. Y. ,
Hsu, S. P. ,
Liang, Y. C. ,
Kuo, M. L. ,
Ho, Y. S. &
Lee, W. S. ,
5月 15 2008 ,
於: Toxicology and Applied Pharmacology. 229 ,
1 ,
p. 86-93 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terbinafine
100%
Extracellular Signal-Regulated MAP Kinases
77%
Endothelial Cells
52%
Up-Regulation
51%
Phosphorylation
49%
Lee, W. S. ,
Chen, R. J. ,
Wang, Y. J. ,
Tseng, H. ,
Jeng, J. H. ,
Lin, S. Y. ,
Liang, Y. C. ,
Chen, C. H. ,
Lin, C. H. ,
Lin, J. K. ,
Ho, P. Y. ,
Chu, J. S. ,
Ho, W. L. ,
Chen, L. C. &
Ho, Y. S. ,
8月 10 2003 ,
於: International Journal of Cancer. 106 ,
1 ,
p. 125-137 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terbinafine
100%
Cell Cycle Checkpoints
69%
Cell Line
42%
In Vitro Techniques
31%
Neoplasms
23%
Wu, C. H. ,
Ho, Y. S. ,
Tsai, C. Y. ,
Wang, Y. J. ,
Tseng, H. ,
Wei, P. L. ,
Lee, C. H. ,
Liu, R. S. &
Lin, S. Y. ,
5月 1 2009 ,
於: International Journal of Cancer. 124 ,
9 ,
p. 2210-2219 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Phloretin
100%
Liver Neoplasms
64%
Apoptosis
39%
Hep G2 Cells
34%
In Vitro Techniques
28%
Tu, S. H. ,
Wu, C. H. ,
Chen, L. C. ,
Huang, C. S. ,
Chang, H. W. ,
Chang, C. H. ,
Lien, H. M. &
Ho, Y. S. ,
4月 11 2012 ,
於: Journal of Agricultural and Food Chemistry. 60 ,
14 ,
p. 3612-3618 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
4,7-dimethoxy-5-methyl-1,3-benzodioxole
100%
Antrodia
68%
Taiwanofungus camphoratus
66%
fruiting bodies
42%
Antitumor
36%
Lin, S-Y. ,
Liang, Y-C. ,
Ho, Y-S. ,
Tsai, S-H. ,
Pan, S. &
Lee, W-S. ,
9月 2002 ,
於: Molecular Carcinogenesis. 35 ,
1 ,
p. 21-28 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
JNK Mitogen-Activated Protein Kinases
100%
Tetradecanoylphorbol Acetate
97%
Extracellular Signal-Regulated MAP Kinases
96%
Colonic Neoplasms
80%
Protein Kinase C
69%
Liu, J-D. ,
Lin, S-Y. ,
Ho, Y-S. ,
Pan, S. ,
Hung, L. F. ,
Tsai, S-H. ,
Lin, J. K. &
Liang, Y-C. ,
5月 1 2003 ,
於: Molecular Carcinogenesis. 37 ,
1 ,
p. 16-24 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
15-deoxy-delta(12,14)-prostaglandin J2
100%
prostaglandin A1
91%
JNK Mitogen-Activated Protein Kinases
62%
Stomach
39%
Epithelial Cells
39%
Liang, Y. C. ,
Wu, C. H. ,
Chu, J. S. ,
Wang, C. K. ,
Hung, L. F. ,
Wang, Y. J. ,
Ho, Y. S. ,
Chang, J. G. &
Lin, S. Y. ,
5月 7 2005 ,
於: World Journal of Gastroenterology. 11 ,
17 ,
p. 2557-2563 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Coenzyme A
100%
Ligases
87%
p38 Mitogen-Activated Protein Kinases
82%
Cyclic AMP
78%
Fatty Acids
68%
Chiang, L. L. ,
Kuo, C. T. ,
Wang, C. H. ,
Chen, T-F. ,
Ho, Y. S. ,
Kuo, H. P. &
Lin, C. H. ,
1月 1 2003 ,
於: Journal of Pharmacy and Pharmacology. 55 ,
1 ,
p. 115-123 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
lipoteichoic acid
100%
Lipoteichoic Acid
81%
Ro 31-8220
72%
Cyclooxygenase 2
72%
U-73122
65%
Lin, C. H. ,
Wu, C. H. ,
Thum, W. Y. ,
Ho, Y. S. &
Lee, H. M. ,
3月 8 2002 ,
於: European Journal of Pharmacology. 438 ,
3 ,
p. 143-152 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Advanced Glycation End Products
100%
p38 Mitogen-Activated Protein Kinases
85%
Lysine
80%
SB 203580
61%
RAW 264.7 Cells
43%
Yang, K-C. ,
Wu, C-C. ,
Wu, C-H. ,
Chen, J. H. ,
Chu, C. H. ,
Chen, C-H. ,
Chou, Y. H. ,
Wang, Y. J. ,
Lee, W-S. ,
Tseng, H. ,
Lin, S-Y. ,
Lee, C-H. &
Ho, Y-S. ,
2月 2006 ,
於: Food and Chemical Toxicology. 44 ,
2 ,
p. 214-226 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terbinafine
100%
HL-60 Cells
69%
Apoptotic
68%
apoptosis
54%
Marker
52%
Lin, C. H. ,
Sheu, S. Y. ,
Lee, H. M. ,
Ho, Y. S. ,
Lee, W. S. ,
Ko, W-C. &
Sheu, J. R. ,
2000 ,
於: Molecular Pharmacology. 57 ,
1 ,
p. 36-43 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cyclooxygenase 2
100%
Interleukin-1
95%
Protein Kinase C
90%
Epithelial Cells
68%
Lung
51%
Hsu, S. P. ,
Ho, P. Y. ,
Liang, Y. C. ,
Ho, Y. S. &
Lee, W. S. ,
11月 1 2009 ,
於: Journal of Cellular Biochemistry. 108 ,
4 ,
p. 860-866 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terbinafine
100%
JNK Mitogen-Activated Protein Kinases
80%
Umbilicus
59%
Endothelial Cells
52%
Up-Regulation
51%
Suk, F. M. ,
Chen, S-H. ,
Ho, Y. S. ,
Pan, S. ,
Lou, H. Y. ,
Chang, C. C. ,
Hsieh, C. R. ,
Cheng, Y-S. &
Lien, G. S. ,
1月 1 2003 ,
於: Chinese Medical Journal (Taipei). 65 ,
10 ,
p. 468-473 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dental Plaque
100%
Helicobacter pylori
75%
Stomach
33%
Therapeutics
12%
Infections
7%
Ho, Y. S. ,
Tsai, P. W. ,
Yu, C. F. ,
Liu, H. L. ,
Chen, R. J. &
Lin, J. K. ,
1998 ,
於: Toxicology and Applied Pharmacology. 153 ,
1 ,
p. 39-47 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ketoconazole
100%
Hepatocellular Carcinoma
58%
Colorectal Neoplasms
58%
Apoptosis
44%
Cell Line
43%
Chen, R. J. ,
Lee, W. S. ,
Liang, Y. C. ,
Lin, J. K. ,
Wang, Y. J. ,
Lin, C. H. ,
Hsieh, J. Y. ,
Chaing, C. C. &
Ho, Y. S. ,
12月 1 2000 ,
於: Toxicology and Applied Pharmacology. 169 ,
2 ,
p. 132-141 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ketoconazole
100%
Hepatocellular Carcinoma
58%
Colorectal Neoplasms
58%
Cell Line
43%
Cell Cycle Resting Phase
33%
Wang, Y. J. ,
Yu, C. F. ,
Chen, L. C. ,
Chen, C. H. ,
Lin, J. K. ,
Liang, Y. C. ,
Lin, C. H. ,
Lin, S. Y. ,
Chen, C. F. &
Ho, Y. S. ,
2002 ,
於: Journal of Cellular Biochemistry. 87 ,
2 ,
p. 147-159 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terfenadine
100%
Ketoconazole
81%
Cytochrome P-450 CYP3A
67%
Cytochrome P450
63%
Hep G2 Cells
63%
Wang, Y. J. ,
Jeng, J. H. ,
Chen, R. J. ,
Tseng, H. ,
Chen, L. C. ,
Liang, Y. C. ,
Lin, C. H. ,
Chen, C. H. ,
Chu, J. S. ,
Ho, W. L. &
Ho, Y. S. ,
2002 ,
於: Molecular Carcinogenesis. 34 ,
4 ,
p. 199-210 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nocodazole
100%
Ketoconazole
89%
Nude Mice
68%
Heterografts
65%
Neoplasms
23%
Huang, M. T. ,
Wei, P. L. ,
Liu, J. J. ,
Liu, D. Z. ,
Huang, H. C. ,
An, J. ,
Wu, C. C. ,
Wu, C. H. ,
Ho, Y. S. ,
Yang, Y. Y. &
Chang, Y. J. ,
12月 2010 ,
於: Annals of Surgical Oncology. 17 ,
12 ,
p. 3379-3385 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thrombomodulin
100%
Cadherins
76%
Cell Movement
61%
Hepatocellular Carcinoma
60%
Gene Expression
45%
Hung, C. S. ,
Liu, H. H. ,
Huang, M. T. ,
Cheng, C. W. ,
Kuo, L. J. ,
Ho, Y. S. ,
Wu, C. H. ,
Chen, C. M. ,
Wei, P. L. &
Chang, Y. J. ,
10月 2012 ,
於: Annals of Surgical Oncology. 19 ,
11 ,
p. 3547-3555 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Survivin
100%
Curcumin
94%
Hepatocellular Carcinoma
67%
Small Interfering RNA
26%
In Situ Nick-End Labeling
22%
Ho, Y. S. ,
Liou, H. B. ,
Lin, J. K. ,
Jeng, J. H. ,
Pan, M. H. ,
Lin, Y. P. ,
Guo, H. R. ,
Ho, S. Y. ,
Lee, C. C. &
Wang, Y. J. ,
2002 ,
於: Archives of Toxicology. 76 ,
8 ,
p. 484-493 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peroxynitrous Acid
100%
Peroxynitrite
98%
Cell Death
84%
Nitric Oxide
75%
Lipid Peroxidation
73%
Ho, Y. S. ,
Ma, H. Y. ,
Chang, H. Y. ,
Wei, B. L. ,
Lee, C. C. ,
Ho, S. Y. ,
Guo, H. R. ,
Wu, T. P. ,
Chang, W. H. &
Wang, Y. J. ,
5月 1 2003 ,
於: Food and Chemical Toxicology. 41 ,
5 ,
p. 621-629 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chloral Hydrate
100%
chloral hydrate
98%
Cell Death
67%
Lipid Peroxidation
58%
cell death
58%
Huang, C. S. ,
Lee, Y. R. ,
Chen, C. S. ,
Tu, S. H. ,
Wang, Y. J. ,
Lee, C. H. ,
Chen, L. C. ,
Chang, H. W. ,
Chang, C. H. ,
Su, C-M. ,
Wu, C. H. &
Ho, Y. S. ,
8月 2010 ,
於: Molecular Carcinogenesis. 49 ,
8 ,
p. 728-738 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mitomycin
100%
Liver Neoplasms
89%
Ethanol
76%
Apoptosis
55%
Hepatitis B virus
21%
Huang, C. S. ,
Ho, C. T. ,
Tu, S. H. ,
Pan, M. H. ,
Chuang, C. H. ,
Chang, H. W. ,
Chang, C. H. ,
Wu, C. H. &
Ho, Y. S. ,
5月 8 2013 ,
於: Journal of Agricultural and Food Chemistry. 61 ,
18 ,
p. 4326-4335 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pterostilbene
100%
pterostilbene
96%
protein-lysine 6-oxidase
91%
Protein-Lysine 6-Oxidase
83%
curcumin
74%
Fararjeh, A-FS. ,
Tu, S-H. ,
Chen, L-C. ,
Cheng, T-C. ,
Liu, Y-R. ,
Chang, H-L. ,
Chang, H-W. ,
Huang, C-C. ,
Wang, H-CR. ,
Hwang-Verslues, W. W. ,
Wu, C-H. &
Ho, Y-S. ,
1月 2019 ,
於: Environmental Toxicology. 34 ,
1 ,
p. 73-82 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
100%
Nicotine
78%
Smoke
72%
Nicotinic Receptors
70%
Acetylcholine
68%
Chen, R. J. ,
Ho, Y. S. ,
Guo, H. R. &
Wang, Y. J. ,
5月 2010 ,
於: Toxicological Sciences. 115 ,
1 ,
p. 118-130 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nicotine
100%
Urinary Bladder Neoplasms
78%
Adrenergic Receptors
77%
Down-Regulation
57%
Small Interfering RNA
45%
Tu, S. H. ,
Ho, C. T. ,
Liu, M. F. ,
Huang, C. S. ,
Chang, H-W. ,
Chang, C. H. ,
Wu, C. H. &
Ho, Y. S. ,
2013 ,
於: Food Chemistry. 141 ,
2 ,
p. 1553-1561 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Luteolin
100%
tamoxifen
97%
Tamoxifen
97%
cyclins
87%
Cyclins
86%
Chen, L. C. ,
Liu, Y. C. ,
Liang, Y. C. ,
Ho, Y. S. &
Lee, W. S. ,
2009 ,
於: Journal of Agricultural and Food Chemistry. 57 ,
16 ,
p. 7331-7337 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Magnolol
93%
glioblastoma
84%
Glioblastoma
57%
cell proliferation
52%
Wang, Y. J. ,
Ho, Y. S. ,
Pan, M. H. &
Lin, J. K. ,
8月 4 1998 ,
於: Environmental Toxicology and Pharmacology. 6 ,
1 ,
p. 35-44 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peroxynitrous Acid
100%
Peroxynitrite
98%
Cell Death
84%
Nitric Oxide
75%
S-Nitrosoglutathione
30%
Lee, W. J. ,
Chen, L. C. ,
Lin, J. H. ,
Cheng, T. C. ,
Kuo, C. C. ,
Wu, C. H. ,
Chang, H. W. ,
Tu, S. H. &
Ho, Y. S. ,
1月 1 2019 ,
於: Cancer Medicine. 8 ,
10 ,
p. 4821-4835 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hyaluronan Synthases
100%
Mitophagy
87%
Melatonin
69%
Neuroblastoma
64%
Cell Differentiation
52%
Lin, C. Y. ,
Lee, C. H. ,
Chuang, Y. H. ,
Lee, J. Y. ,
Chiu, Y. Y. ,
Wu Lee, Y. H. ,
Jong, Y. J. ,
Hwang, J. K. ,
Huang, S. H. ,
Chen, L. C. ,
Wu, C. H. ,
Tu, S. H. ,
Ho, Y. S. &
Yang, J. M. ,
12月 1 2019 ,
於: Nature Communications. 10 ,
1 , 3131.
研究成果: 雜誌貢獻 › 文章 › 同行評審
cancer
100%
Membrane Proteins
88%
proteins
85%
membranes
77%
Antimetastatic Agent
46%
Hung, C-S. ,
Liu, H. H. ,
Liu, J-J. ,
Yeh, C-T. ,
Chang, T-C. ,
Wu, C-H. ,
Ho, Y-S. ,
Wei, P-L. &
Chang, Y-J. ,
2013 ,
於: Annals of Surgical Oncology. 20 ,
3 SUPPL. ,
p. S360-S368 研究成果: 雜誌貢獻 › 文章 › 同行評審
Epithelial-Mesenchymal Transition
100%
MicroRNAs
81%
Cell Movement
78%
Hepatocellular Carcinoma
77%
Cadherins
43%
Tseng, C. J. ,
Wang, Y. J. ,
Liang, Y. C. ,
Jeng, J. H. ,
Lee, W. S. ,
Lin, J. K. ,
Chen, C. H. ,
Liu, I. C. &
Ho, Y. S. ,
6月 14 2002 ,
於: Toxicology. 175 ,
1-3 ,
p. 123-142 20 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nocodazole
100%
Podophyllotoxin
83%
G2 Phase Cell Cycle Checkpoints
80%
HT29 Cells
72%
Paclitaxel
70%
Lin, S. Y. ,
Chang, Y. T. ,
Liu, J-D. ,
Yu, C. H. ,
Ho, Y. S. ,
Lee, Y-H. &
Lee, W. S. ,
2001 ,
於: Molecular Carcinogenesis. 32 ,
2 ,
p. 73-83 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Liver Neoplasms
60%
Colonic Neoplasms
54%
Caspase 8
41%
Apoptosis
36%
Yang, K-C. ,
Uen, Y. H. ,
Suk, F. M. ,
Liang, Y. C. ,
Wang, Y. J. ,
Ho, Y. S. ,
Li, I. H. &
Lin, S. Y. ,
5月 28 2005 ,
於: World Journal of Gastroenterology. 11 ,
20 ,
p. 3040-3045 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
denbinobin
100%
Colonic Neoplasms
41%
Carcinogenesis
35%
Apoptosis Inducing Factor
13%
Apoptosis
11%
Ho, Y. S. ,
Wu, C. H. ,
Chou, H. M. ,
Wang, Y. J. ,
Tseng, H. ,
Chen, C. H. ,
Chen, L. C. ,
Lee, C. H. &
Lin, S. Y. ,
10月 2005 ,
於: Food and Chemical Toxicology. 43 ,
10 ,
p. 1483-1495 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Econazole
100%
caspase-8
90%
cell cycle checkpoints
76%
G1 Phase Cell Cycle Checkpoints
76%
colorectal neoplasms
71%
Liu, J. D. ,
Wang, Y. J. ,
Chen, C. H. ,
Yu, C. F. ,
Chen, L. C. ,
Lin, J. K. ,
Liang, Y. C. ,
Lin, S. Y. &
Ho, Y. S. ,
5月 1 2003 ,
於: Molecular Carcinogenesis. 37 ,
1 ,
p. 39-50 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Terfenadine
100%
G1 Phase Cell Cycle Checkpoints
87%
Apoptosis
40%
Neoplasms
21%
Oligodeoxyribonucleotides
13%
Chen, R. J. ,
Ho, Y. S. ,
Wu, C. H. &
Wang, Y. J. ,
12月 2011 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 3 ,
6 ,
p. 252-256 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nicotine
100%
Urinary Bladder Neoplasms
96%
pterostilbene
50%
Smoke
28%
Nicotinic Receptors
22%
Hsieh, Y. C. ,
Cho, E. C. ,
Tu, S. H. ,
Wu, C. H. ,
Hung, C. S. ,
Hsieh, M-C. ,
Su, C. T. ,
Liu, Y-R. ,
Lee, C. H. ,
Ho, Y. S. &
Chiou, H. Y. ,
2月 1 2017 ,
於: Annals of Surgical Oncology. 24 ,
2 ,
p. 603-610 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Breast Neoplasms
64%
DNA Mismatch Repair
60%
Single Nucleotide Polymorphism
42%
Luciferases
31%
Tsai, H. T. ,
Huang, C. S. ,
Tu, C. C. ,
Liu, C. Y. ,
Huang, C. J. ,
Ho, Y. S. ,
Tu, S. H. ,
Tseng, L. M. &
Huang, C. C. ,
12月 1 2020 ,
於: Scientific Reports. 10 ,
1 , 18276.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Calcinosis
100%
Carcinoma, Intraductal, Noninfiltrating
67%
Breast Neoplasms
51%
Genes
32%
Messenger RNA
19%
Wang, H. ,
Ellipilli, S. ,
Lee, W. J. ,
Li, X. ,
Vieweger, M. ,
Ho, Y. S. &
Guo, P. ,
2月 10 2021 ,
於: Journal of Controlled Release. 330 ,
p. 173-184 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Paclitaxel
100%
Rubber
98%
Liver Neoplasms
82%
Drug Resistance
75%
Nanoparticles
73%
Chen, C. S. ,
Wu, C. H. ,
Lai, Y. C. ,
Lee, W. S. ,
Chen, H. M. ,
Chen, R. J. ,
Chen, L. C. ,
Ho, Y. S. &
Wang, Y. J. ,
4月 18 2008 ,
於: Toxicology. 246 ,
2-3 ,
p. 148-157 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pinocembrin
100%
Propolis
85%
transglutaminase 2
80%
Ethanol
51%
Thioacetamide
40%
Uen, Y. H. ,
Liu, D. Z. ,
Weng, M. S. ,
Ho, Y. S. &
Lin, S. Y. ,
8月 1 2007 ,
於: Journal of Cellular Biochemistry. 101 ,
5 ,
p. 1165-1175 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Griseofulvin
100%
HL-60 Cells
79%
Apoptosis
41%
Tosylphenylalanyl Chloromethyl Ketone
39%
G2 Phase Cell Cycle Checkpoints
31%
Wei, P. L. ,
Kuo, L. J. ,
Huang, M. T. ,
Ting, W. C. ,
Ho, Y. S. ,
Wang, W. ,
An, J. &
Chang, Y. J. ,
6月 2011 ,
於: Annals of Surgical Oncology. 18 ,
6 ,
p. 1782-1790 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nicotine
100%
Fibronectins
98%
Colonic Neoplasms
91%
Cell Movement
82%
Epithelial-Mesenchymal Transition
20%
Chen, C. S. ,
Lee, C-H. ,
Hsieh, C. D. ,
Ho, C. T. ,
Pan, M. H. ,
Huang, C. S. ,
Tu, S-H. ,
Wang, Y. J. ,
Chen, L-C. ,
Chang, Y-J. ,
Wei, P-L. ,
Yang, Y-Y. ,
Wu, C-H. &
Ho, Y-S. ,
1月 2011 ,
於: Breast Cancer Research and Treatment. 125 ,
1 ,
p. 73-87 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
garcinol
100%
Cyclin D3
81%
Nicotinic Receptors
60%
Nicotine
54%
Down-Regulation
38%
Lien, Y. C. ,
Wang, W. ,
Kuo, L. J. ,
Liu, J. J. ,
Wei, P. L. ,
Ho, Y. S. ,
Ting, W. C. ,
Wu, C. H. &
Chang, Y. J. ,
9月 2011 ,
於: Annals of Surgical Oncology. 18 ,
9 ,
p. 2671-2679 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
alpha7 Nicotinic Acetylcholine Receptor
100%
Nicotine
58%
Stomach Neoplasms
50%
Cell Movement
48%
Cadherins
13%
Carcinogens
100%
Hepatocellular Carcinoma
83%
Subcutaneous Injections
72%
Intraperitoneal Injections
67%
Fibroadenoma
46%
Wang, W. ,
Hung, C-S. ,
Kuo, L-J. ,
Wei, P-L. ,
Lien, Y-C. ,
Lin, F-Y. ,
Liu, H. H. ,
Ho, Y-S. ,
Wu, C-H. &
Chang, Y-J. ,
7月 2012 ,
於: Annals of Surgical Oncology. 19 ,
SUPPL. 3 ,
p. S580-S588 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nicotinic Receptors
100%
Fibronectins
88%
Stomach Neoplasms
78%
Cell Movement
74%
alpha7 Nicotinic Acetylcholine Receptor
56%